Published in J Clin Invest on March 15, 1997
The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol (2001) 1.56
Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends Mol Med (2011) 1.06
Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J Clin Invest (1998) 0.95
B cells in multiple sclerosis. Front Biosci (2004) 0.86
Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. J Clin Immunol (2007) 0.84
Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients. J Immunol (2010) 0.82
Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders. Front Immunol (2017) 0.75
Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients. Acta Neuropathol (2016) 0.75
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem (1972) 4.87
Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell (1996) 3.48
Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science (1983) 2.91
A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell (1987) 2.58
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med (1994) 2.45
Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med (1995) 2.09
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol (1986) 2.06
An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol (1992) 2.03
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature (1993) 2.01
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89
Molecular mimicry and the generation of host defense protein diversity. Cell (1993) 1.78
The preparation of crystalline transaldolase from Candida utilis. Proc Natl Acad Sci U S A (1961) 1.65
A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell (1989) 1.63
On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol (1985) 1.56
T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis. Proc Natl Acad Sci U S A (1989) 1.47
Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci U S A (1991) 1.47
Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol (1992) 1.40
SEQUENCE OF MYELINIZATION IN THE BRAIN OF THE ALBINO RAT. A. CEREBRAL CORTEX, THALAMUS AND RELATED STRUCTURES. J Comp Neurol (1963) 1.36
T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med (1992) 1.30
Cloning and expression of the human gene for transaldolase. A novel highly repetitive element constitutes an integral part of the coding sequence. J Biol Chem (1994) 1.23
Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol (1990) 1.18
Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells. Cell Immunol (1984) 1.10
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med (1994) 1.05
Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. J Immunol (1991) 0.98
Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease. J Clin Invest (1996) 0.97
Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesis. FEBS Lett (1996) 0.95
Glucose metabolism in brain tissue: the hexosemonophosphate shunt and its role in glutathione reduction. J Neurochem (1962) 0.92
Aspects of carbohydrate metabolism in developing brain. Dev Med Child Neurol (1977) 0.89
Characterization of T-cell receptor V beta usage in the brain of a subject with multiple sclerosis. Ann N Y Acad Sci (1995) 0.83
Human endogenous retroviral elements and autoimmunity: data and concepts. Trends Microbiol (1993) 0.83
TCR peptide therapy in autoimmune diseases. Int Rev Immunol (1993) 0.81
Heterogeneity of the T-cell receptor beta gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. Ann Neurol (1991) 0.80
Analogous amino acid sequences in myelin proteolipid and viral proteins. FEBS Lett (1986) 0.80
Human retrovirus and multiple sclerosis. Mayo Clin Proc (1991) 0.78
Independence of depressed lectin-dependent cell-mediated cytotoxicity from interleukin 2 production in patients with systemic lupus erythematosus. Clin Exp Immunol (1986) 0.77
The T-cell receptor in multiple sclerosis. Ann N Y Acad Sci (1995) 0.76
T-cell receptor use in multiple sclerosis. Ann N Y Acad Sci (1995) 0.76
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33
B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol (1999) 2.06
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature (1993) 2.01
Myxovirus antibody increases in human connective tissue disease. Science (1970) 1.94
T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood (2000) 1.94
Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. AIDS (2000) 1.91
Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol (1999) 1.88
Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program. AIDS (1998) 1.86
Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. Neurology (2004) 1.73
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Identification by polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD. J Med Vet Mycol (1998) 1.57
Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy. Lancet (1998) 1.50
Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids. Arthritis Rheum (1992) 1.47
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). Ann Oncol (2001) 1.45
Gastropericardial fistula--a complication of hiatus hernia. Br J Surg (1974) 1.43
Hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol (1992) 1.39
False-positive antineutrophil cytoplasmic antibody in aspergillosis with oxalosis. Arch Pathol Lab Med (1995) 1.39
Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet (1997) 1.34
Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology (2007) 1.32
Human transaldolase-associated repetitive elements are transcribed by RNA polymerase III. J Biol Chem (2000) 1.31
Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci U S A (1992) 1.30
Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis. Proc Natl Acad Sci U S A (1993) 1.29
Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J Biol Chem (1996) 1.28
A novel atypical 22q11.2 distal deletion in father and son. J Med Genet (2002) 1.27
Patients appreciate premedication for endoscopy. Lancet (1980) 1.27
Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial. Anesth Analg (1990) 1.25
Cloning and expression of the human gene for transaldolase. A novel highly repetitive element constitutes an integral part of the coding sequence. J Biol Chem (1994) 1.23
Alteration of ethanol self-administration by naltrexone. Life Sci (1980) 1.23
Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology (2004) 1.22
Virus antibodies in systemic lupus erythematosus and other connective tissue diseases. Ann Rheum Dis (1973) 1.21
JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.19
Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J (1992) 1.17
The three-dimensional structure of human transaldolase. FEBS Lett (2000) 1.17
Familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol (1999) 1.16
Sub-second changes in accumbal dopamine during sexual behavior in male rats. Neuroreport (2001) 1.14
Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia. Proc Natl Acad Sci U S A (1988) 1.14
Experimental rubella virus infection in the rhesus monkey. J Immunol (1965) 1.13
PCR amplification of highly GC-rich DNA template after denaturation by NaOH. Nucleic Acids Res (1993) 1.11
Viruses and autoimmunity. Am J Med (1973) 1.10
Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology (1988) 1.10
Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells. Cell Immunol (1984) 1.10
Bengamides revisited: new structures and antitumor studies. J Org Chem (2001) 1.10
Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women. J Infect Dis (2000) 1.09
The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects. Am J Pathol (1976) 1.09
Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J (2000) 1.08
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS (2000) 1.07
Human T-cell leukemia virus type I or a related retrovirus in patients with mycosis fungoides/Sézary syndrome and Kaposi's sarcoma. Cancer Res (1992) 1.07
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med (1994) 1.05
Lysine and threonine metabolism are subject to complex patterns of regulation in Arabidopsis. Plant Mol Biol (1996) 1.05
Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J Biol Chem (1998) 1.04
Gluten-sensitive disease with mild enteropathy. Gastroenterology (1996) 1.03
Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1992) 1.02
Restriction endonuclease digestion eliminates product contamination in reverse transcribed polymerase chain reaction. J Virol Methods (1993) 1.02
Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Antioxid Redox Signal (2000) 1.02
Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia. Ann Neurol (1988) 1.02
Tetrachlorodibenzodioxin: an accidental poisoning episode in horse arenas. Science (1975) 0.98
Terminal effects of ethanol on dopamine dynamics in rat nucleus accumbens: an in vitro voltammetric study. Synapse (2001) 0.98
Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J Neuroimmunol (2001) 0.97
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. Neurology (2001) 0.97
HMB-45-positive malignant lymphoma. A case report with literature review of aberrant HMB-45 reactivity. Arch Pathol Lab Med (1991) 0.97
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies. Clin Microbiol Infect (2011) 0.96
Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals. J Neurovirol (1999) 0.95
Frequency and clinical pattern of celiac disease among siblings of celiac children. J Pediatr Gastroenterol Nutr (1996) 0.95
A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ(alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1992) 0.95
Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesis. FEBS Lett (1996) 0.95
Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum (1995) 0.94
Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Biochem Biophys Res Commun (1997) 0.94
Synthesis and antitumor activity of ester-modified analogues of bengamide B. J Med Chem (2001) 0.94
Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats. J Pharmacol Exp Ther (2001) 0.94
Entry of coronavirus into primate CNS following peripheral infection. Microb Pathog (1994) 0.93
Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritis. J Rheumatol (1995) 0.93
Virus antibody levels and delayed hypersensitivity in rheumatoid arthritis. Ann Rheum Dis (1976) 0.93
HTLV-II infection in Italian drug abusers. Lancet (1990) 0.92
The virus hypothesis in systemic lupus erythematosus. Ann Intern Med (1975) 0.92
Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol (2000) 0.92
Outbreak of persistent, unexplained, generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan. Infection (1985) 0.91
Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. Am J Cardiol (1983) 0.91
Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids. Arthritis Rheum (1981) 0.91
Intracellular detection of sense and antisense enteroviral RNA by in situ hybridization. J Virol Methods (1988) 0.91
High IgM antibody to human T-lymphotropic virus type I in systemic lupus erythematosus. J Clin Immunol (1986) 0.90
The effect of synthetic malaria pigment (beta-haematin) on adhesion molecule expression and interleukin-6 production by human endothelial cells. Trans R Soc Trop Med Hyg (1998) 0.90
Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b. J Neurovirol (2000) 0.90
Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics (1999) 0.89
Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus. Lupus (2009) 0.89
A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun (2007) 0.89
Relationship between posttranslational modification of transaldolase and catalase deficiency in UV-sensitive repair-deficient xeroderma pigmentosum fibroblasts and SV40-transformed human cells. Free Radic Biol Med (2001) 0.88
Cellular immune responses to cartilage components in rheumatoid arthritis and osteoarthritis: a review and report of a study. Clin Exp Rheumatol (1988) 0.88
Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. AIDS Res Hum Retroviruses (1996) 0.88
The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions. Neurology (1991) 0.88
Meningoencephalitis caused by human herpesvirus-6 in an immunocompetent adult patient: case report and review of the literature. Infection (1999) 0.88